What is the address of LD-Oncologic?

The registered office of LD-Oncologic is located at Rue des Ecoles 7, 5520 Onhaye.

Is LD-Oncologic still active?

Yes. According to the CBE (30 October 2026) LD-Oncologic is active, legal situation “Normale toestand”, started on 26 April 2013.

Is LD-Oncologic registered on Peppol?

Yes, LD-Oncologic is registered on the Peppol network with ID 0208:0533702512.

What is the enterprise number of LD-Oncologic?

The enterprise number of LD-Oncologic is BE0533702512.

When was LD-Oncologic founded?

LD-Oncologic was founded on 26 April 2013.

Who are the directors of LD-Oncologic?

According to the 2025 annual accounts, the directors of LD-Oncologic are: VIRGINIE DI SILVERIO, CHRISTOPHE LONCHAY.

Is LD-Oncologic a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 April 2013; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did LD-Oncologic make in 2025?

LD-Oncologic posted a profit after taxes of € 39,623 in financial year 2025.

What is the revenue of LD-Oncologic?

As a small company, LD-Oncologic is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 69,307.

LD-Oncologic (Private Limited) - Onhaye - BE0533702512

Dossier LD-Oncologic, printed on 30 October 2026 from databakkes.be/en/0533702512/ld-oncologic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LD-Oncologic from Onhaye, company number BE0533702512, closed financial year 2025 with a result of € 39,623 after tax. For that financial year LD-Oncologic recorded a gross margin of € 69,307 and equity of € 140,314. Compared with financial year 2024, the result moved from € 34,746 to € 39,623. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 140,314

▲ 24% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 39,623

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 39,475

▲ 148% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 127,914.

People and assets in 2025

Vehicles and equipment

€ 453

▼ 56% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 101,292

▼ 5% vs 2024

€ 6,050 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 4,372

▼ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,397

▲ 24% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 183,758 Revenue 2022: € 183,758 First fiscal year in the series	€ 181,408 Revenue 2023: € 181,408 ▼ 1% vs 2022 (€ 183,758) Unfavourable step	-	-
Gross margin	€ 41,005 Gross margin 2022: € 41,005 First fiscal year in the series	€ 23,707 Gross margin 2023: € 23,707 ▼ 42% vs 2022 (€ 41,005) Unfavourable step	€ 62,460 Gross margin 2024: € 62,460 ▲ 163% vs 2023 (€ 23,707) Favourable step	€ 69,307 Gross margin 2025: € 69,307 ▲ 11% vs 2024 (€ 62,460) Favourable step	▲ 11%
Profit after taxes	€ 11,936 Profit after taxes 2022: € 11,936 First fiscal year in the series	€ 7,706 Profit after taxes 2023: € 7,706 ▼ 35% vs 2022 (€ 11,936) Unfavourable step	€ 34,746 Profit after taxes 2024: € 34,746 ▲ € 27,040 vs 2023 (€ 7,706) Favourable step	€ 39,623 Profit after taxes 2025: € 39,623 ▲ 14% vs 2024 (€ 34,746) Favourable step	▲ 14%
Equity	€ 71,007 Equity 2022: € 71,007 First fiscal year in the series	€ 78,713 Equity 2023: € 78,713 ▲ 11% vs 2022 (€ 71,007) Favourable step	€ 113,459 Equity 2024: € 113,459 ▲ 44% vs 2023 (€ 78,713) Favourable step	€ 140,314 Equity 2025: € 140,314 ▲ 24% vs 2024 (€ 113,459) Favourable step	▲ 24%
Total debts	€ 26,887 Total debts 2022: € 26,887 First fiscal year in the series	€ 14,354 Total debts 2023: € 14,354 ▼ 47% vs 2022 (€ 26,887) Favourable step	€ 130,786 Total debts 2024: € 130,786 ▲ € 116,432 vs 2023 (€ 14,354) Unfavourable step	€ 128,136 Total debts 2025: € 128,136 ▼ 2% vs 2024 (€ 130,786) Favourable step	▼ 2%
Cash	€ 27,439 Cash 2022: € 27,439 First fiscal year in the series	€ 17,912 Cash 2023: € 17,912 ▼ 35% vs 2022 (€ 27,439) Unfavourable step	€ 15,893 Cash 2024: € 15,893 ▼ 11% vs 2023 (€ 17,912) Unfavourable step	€ 39,475 Cash 2025: € 39,475 ▲ 148% vs 2024 (€ 15,893) Favourable step	▲ 148%
Land & buildings	-	-	€ 138,271 Land & buildings 2024: € 138,271 First fiscal year in the series	€ 150,647 Land & buildings 2025: € 150,647 ▲ 9% vs 2024 (€ 138,271) Unchanged	▲ 9%
Retained profit	€ 58,607 Retained profit 2022: € 58,607 First fiscal year in the series	€ 66,313 Retained profit 2023: € 66,313 ▲ 13% vs 2022 (€ 58,607) Favourable step	€ 101,059 Retained profit 2024: € 101,059 ▲ 52% vs 2023 (€ 66,313) Favourable step	€ 127,914 Retained profit 2025: € 127,914 ▲ 27% vs 2024 (€ 101,059) Favourable step	▲ 27%
Bank debt	€ 17,045 Bank debt 2022: € 17,045 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 17,045) Favourable step	€ 107,145 Bank debt 2024: € 107,145 Unchanged (€ 0) Unfavourable step	€ 101,292 Bank debt 2025: € 101,292 ▼ 5% vs 2024 (€ 107,145) Favourable step	▼ 5%
Balance sheet total	€ 97,894 Balance sheet total 2022: € 97,894 First fiscal year in the series	€ 93,067 Balance sheet total 2023: € 93,067 ▼ 5% vs 2022 (€ 97,894) Unchanged	€ 244,245 Balance sheet total 2024: € 244,245 ▲ 162% vs 2023 (€ 93,067) Unchanged	€ 268,450 Balance sheet total 2025: € 268,450 ▲ 10% vs 2024 (€ 244,245) Unchanged	▲ 10%

Key figures of LD-Oncologic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LD-Oncologic?

What happened at LD-Oncologic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 39,623 (▲ 14% vs 2024). Source: NBB ↗
Apr 26, 2013 New establishment in Onhaye. KBO
Apr 26, 2013 Start of the company according to the CBE. KBO

In short

From € 11,936 profit in 2022 to € 39,623 profit in 2025.

Paid € 41,155 in corporate taxes since 2022.

Best year ever: 2025, with € 39,623 profit.

Original PDFs at the National Bank ↗

Management

VIRGINIE DI SILVERIO CHRISTOPHE LONCHAY

LD-Oncologic

Behind LD-Oncologic are VIRGINIE DI SILVERIO and CHRISTOPHE LONCHAY.

Directors

According to the 2025 annual accounts

VIRGINIE DI SILVERIO

Director

CHRISTOPHE LONCHAY

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Ecoles 7

5520 Onhaye

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0533.702.512
VAT number: BE 0533.702.512
Registered office: Rue des Ecoles 7, 5520 Onhaye
Names & denominations: LD-Oncologic
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 April 2013
Peppol: Active · Active since 24 Aug 2026

View on CBE Public ↗ Annual accounts (NBB) ↗